These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 28542298)
1. Early anti-TNF/immunomodulator therapy is associated with better long-term clinical outcomes in Asian patients with Crohn's disease with poor prognostic factors. Oh EH; Oh K; Han M; Seo H; Chang K; Lee SH; Kim GU; Song EM; Seo M; Lee HS; Hwang SW; Park SH; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yang SK; Ye BD PLoS One; 2017; 12(5):e0177479. PubMed ID: 28542298 [TBL] [Abstract][Full Text] [Related]
2. Timing of Thiopurine or Anti-TNF Initiation Is Associated with the Risk of Major Abdominal Surgery in Crohn's Disease: A Retrospective Cohort Study. González-Lama Y; Suárez C; González-Partida I; Calvo M; Matallana V; de la Revilla J; Magaz M; Bernardo C; Agudo B; Ibarrola P; Relea L; Arévalo J; Vera MI; Abreu L J Crohns Colitis; 2016 Jan; 10(1):55-60. PubMed ID: 26520164 [TBL] [Abstract][Full Text] [Related]
3. Immunomodulators are associated with a lower risk of first surgery among patients with non-penetrating non-stricturing Crohn's disease. Picco MF; Zubiaurre I; Adluni M; Cangemi JR; Shelton D Am J Gastroenterol; 2009 Nov; 104(11):2754-9. PubMed ID: 19584832 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of tumour necrosis factor antagonists in stricturing Crohn's disease: A tertiary center real-life experience. Allocca M; Bonifacio C; Fiorino G; Spinelli A; Furfaro F; Balzarini L; Bonovas S; Danese S Dig Liver Dis; 2017 Aug; 49(8):872-877. PubMed ID: 28416240 [TBL] [Abstract][Full Text] [Related]
5. Crohn's disease prognosis and early immunomodulator therapy: Results from the CONNECT study. Kim B; Cheon JH; Moon HJ; Park YR; Ye BD; Yang SK; Seo GS; Jang BI; Kim YS; Kim JS; Han DS; Kim YH; Kim WH J Gastroenterol Hepatol; 2016 Jan; 31(1):126-32. PubMed ID: 26406334 [TBL] [Abstract][Full Text] [Related]
6. Impact of medical therapy on patients with Crohn's disease requiring surgical resection. Fu YT; Hong T; Round A; Bressler B World J Gastroenterol; 2014 Sep; 20(33):11808-14. PubMed ID: 25206286 [TBL] [Abstract][Full Text] [Related]
7. Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's disease. Safroneeva E; Vavricka SR; Fournier N; Pittet V; Peyrin-Biroulet L; Straumann A; Rogler G; Schoepfer AM; Aliment Pharmacol Ther; 2015 Oct; 42(8):977-89. PubMed ID: 26271358 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Mesalazine, Thiopurines and Tumour Necrosis Factor Antagonists in Preventing Post-Operative Crohn's Disease Recurrence in a Real-Life Setting. Allocca M; Landi R; Bonovas S; Fiorino G; Papa A; Spinelli A; Furfaro F; Peyrin-Biroulet L; Armuzzi A; Danese S Digestion; 2017; 96(3):166-172. PubMed ID: 28903094 [TBL] [Abstract][Full Text] [Related]
9. Risk Factors for Rescue Therapy in Crohn's Patients Maintained on Infliximab After Withdrawal of the Immunomodulator: A Long-Term Follow-Up. Fischer M; Campbell SC; Calley CSJ; Helper DJ; Chiorean MV; Fadda HM Dig Dis Sci; 2017 Nov; 62(11):3131-3137. PubMed ID: 28986660 [TBL] [Abstract][Full Text] [Related]
10. Anti-tumor necrosis factor therapy decreases the risk of initial intestinal surgery after diagnosis of Crohn's disease of inflammatory type. Nagata Y; Esaki M; Moriyama T; Hirano A; Umeno J; Maehata Y; Torisu T; Matsumoto T; Kitazono T J Gastroenterol; 2019 Apr; 54(4):330-338. PubMed ID: 30244398 [TBL] [Abstract][Full Text] [Related]
11. Phenotypic features of Crohn's disease associated with failure of medical treatment. Moran GW; Dubeau MF; Kaplan GG; Yang H; Seow CH; Fedorak RN; Dieleman LA; Barkema HW; Ghosh S; Panaccione R; Clin Gastroenterol Hepatol; 2014 Mar; 12(3):434-42.e1. PubMed ID: 23978351 [TBL] [Abstract][Full Text] [Related]
12. Significant risk and associated factors of active tuberculosis infection in Korean patients with inflammatory bowel disease using anti-TNF agents. Kim ES; Song GA; Cho KB; Park KS; Kim KO; Jang BI; Kim EY; Jeon SW; Lee HS; Yang CH; Lee YK; Lee DW; Kim SK; Kim TO; Lee J; Kim HW; Jee SR; Park SJ; Kim HJ World J Gastroenterol; 2015 Mar; 21(11):3308-16. PubMed ID: 25805938 [TBL] [Abstract][Full Text] [Related]
13. Medical Therapies for Stricturing Crohn's Disease: Efficacy and Cross-Sectional Imaging Predictors of Therapeutic Failure. Campos C; Perrey A; Lambert C; Pereira B; Goutte M; Dubois A; Goutorbe F; Dapoigny M; Bommelaer G; Hordonneau C; Buisson A Dig Dis Sci; 2017 Jun; 62(6):1628-1636. PubMed ID: 28401425 [TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of patients with Crohn's disease who discontinued infliximab therapy upon clinical remission. Papamichael K; Vande Casteele N; Gils A; Tops S; Hauenstein S; Singh S; Princen F; Van Assche G; Rutgeerts P; Vermeire S; Ferrante M Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1103-10. PubMed ID: 25478919 [TBL] [Abstract][Full Text] [Related]
15. Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn's disease. Rodríguez-Lago I; Hoyo JD; Pérez-Girbés A; Garrido-Marín A; Casanova MJ; Chaparro M; Fernández-Clotet A; Castro-Poceiro J; García MJ; Sánchez S; Ferreiro-Iglesias R; Bastón I; Piqueras M; Careda LEIB; Mena R; Suárez C; Cordón JP; López-García A; Márquez L; Arroyo M; Alfambra E; Sierra M; Cano N; Delgado-Guillena P; Morales-Alvarado V; Aparicio JC; Guerra I; Aulló C; Merino O; Arranz L; Hidalgo MA; Llaó J; Plaza R; Molina G; Torres P; Pérez-Galindo P; Romero MG; Herrera-deGuise C; Armesto E; Mesonero F; Frago-Larramona S; Benítez JM; Calvo M; Martín MDCL; Elorza A; Larena A; Peña E; Rodríguez-Grau MDC; Miguel-Criado J; Botella B; Olmos JA; López L; Aguirre U; Gisbert JP; United European Gastroenterol J; 2020 Nov; 8(9):1056-1066. PubMed ID: 32723069 [TBL] [Abstract][Full Text] [Related]
16. Changes in the Long-term Prognosis of Crohn's Disease between 1986 and 2015: The Population-Based Songpa-Kangdong Inflammatory Bowel Disease Cohort Study. Ye BD; Hong SN; Seo SI; Kim YJ; Cha JM; Rhee KH; Yoon H; Kim YH; Kim KH; Park SY; Jeong SK; Lee JH; Park H; Kim JS; Im JP; Kim SH; Jang J; Kim JH; Suh SO; Kim YK; Park SH; Yang SK; Gut Liver; 2022 Mar; 16(2):216-227. PubMed ID: 34148870 [TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance enterography findings as predictors of clinical outcome following antitumor necrosis factor treatment in small bowel Crohn's disease. Gibson DJ; Murphy DJ; Smyth AE; McEvoy SH; Keegan D; Byrne K; Mulcahy HE; Cullen G; Malone DE; Doherty GA Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):956-62. PubMed ID: 26049706 [TBL] [Abstract][Full Text] [Related]
18. Cumulative incidence of, risk factors for, and outcome of dermatological complications of anti-TNF therapy in inflammatory bowel disease: a 14-year experience. Fréling E; Baumann C; Cuny JF; Bigard MA; Schmutz JL; Barbaud A; Peyrin-Biroulet L Am J Gastroenterol; 2015 Aug; 110(8):1186-96. PubMed ID: 26195181 [TBL] [Abstract][Full Text] [Related]
19. Examination Under Anesthesia May Not Be Universally Required Prior to Anti-TNF Therapy in Perianal Crohn's Disease: A Comparative Cohort Study. Chan M; Fung M; Chin Koon Siw K; Khanna R; de Buck van Overstraeten A; Sabri E; McCurdy JD Inflamm Bowel Dis; 2023 May; 29(5):763-770. PubMed ID: 35815783 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic Delay Is Associated with a Greater Risk of Early Surgery in a French Cohort of Crohn's Disease Patients. Nahon S; Lahmek P; Paupard T; Lesgourgues B; Chaussade S; Peyrin-Biroulet L; Abitbol V Dig Dis Sci; 2016 Nov; 61(11):3278-3284. PubMed ID: 27207180 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]